|
|
Volumn 374, Issue 11, 2016, Pages 1093-
|
|
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes: To the editor
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EMPAGLIFLOZIN;
GLYCOSYLATED HEMOGLOBIN;
ANTIDIABETIC AGENT;
BENZHYDRYL DERIVATIVE;
GLUCOSIDE;
BODY MASS;
CARDIOVASCULAR DISEASE;
HUMAN;
LETTER;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
FEMALE;
MALE;
BENZHYDRYL COMPOUNDS;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
FEMALE;
GLUCOSIDES;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
|
|
EID: 84961798853
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1600827 Document Type: Letter |
|
Times cited : (40)
|
|
References (1)
|
